MIPI Files for Chapter 11, and Gets $45M Financing
By Catherine Shaffer
Monday, December 13, 2010
Molecular Insight Pharmaceuticals Inc. will undergo a corporate reorganization under a Chapter 11 filing pursuant to a $45 million financing commitment from Savitr Capital LLC.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.